Recursion Pharmaceuticals' strategic updates prompted a price target revision by Morgan Stanley on June 26, 2025.

The entities involved

• Morgan Stanley →

  U.S. investment bank

  • Financial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Mon 17:33
  • Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24
• Recursion (United States) →

  company in Salt Lake City, United States

  • Recursion (United States) disclosed insider trading via required filings with the SEC on June 6, 2026.Sun 17:12
  • Trump's pledge to unleash oil and gas benefits stocks, involving Willis Towers Watson.Sun 05:14

Related events

• MarketBeat is providing analyst ratings for Recursion Pharmaceuticals.Sep 20
• Recursion Pharmaceuticals is listed on Nasdaq, and BioCardia, Inc. is a company developing therapeutics in the United States.Sep 7
• Morgan Stanley analysts hiked price targets for Salesforce.Aug 27
• Morgan Stanley set a $96.00 target price, and Citigroup raised its target price and gave a buy rating.Aug 16
• Victory Capital, Royal Bank of Canada, and Morgan Stanley released research notes and raised price targets on August 12, 2026.Aug 12